SCHEMBL4183936

SCHEMBL4183936

CC(C)(C)OC(=O)NCCCc1cc2c3c(c1)c(=O)c(C(=O)O)cn3COC2.[Na]

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.37
P2RY14 Q15391 1/20 0.34
GSK3B P49841 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP3A43 Q9HB55 1/20 0.33
NAMPT P43490 1/20 0.33
DRD2 P14416 1/20 0.33
ATR Q13535 1/20 0.32
ATRIP Q8WXE1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183931 0.98 SIGMAR1 (0.37) SIGMAR1P2RY14GSK3BMEN1GAA
SCHEMBL4169255 0.90 SIGMAR1 (0.38) SIGMAR1P2RY14GSK3BCYP1A1CYP2D6
SCHEMBL4183933 0.90 SIGMAR1 (0.35) SIGMAR1P2RY14CA1CA2MEN1
SCHEMBL4174568 0.89 KDM4E (0.34) SIGMAR1MEN1KMT2ACCNCCDK8
SCHEMBL5433734 0.86 SIGMAR1 (0.40) SIGMAR1P2RY14GSK3BCA1CA2
SCHEMBL5435573 0.85 SIGMAR1 (0.40) SIGMAR1P2RY14GSK3BMEN1GAA
SCHEMBL3975810 0.85 MTNR1A (0.41) SIGMAR1P2RY14MEN1KMT2AKDM4E
SCHEMBL5433728 0.85 SIGMAR1 (0.40) SIGMAR1P2RY14GSK3BMEN1GAA
SCHEMBL4173224 0.83 GSK3B (0.38) SIGMAR1P2RY14GSK3BCA1CA2
SCHEMBL4186330 0.83 SIGMAR1 (0.36) SIGMAR1P2RY14GSK3BCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090062218-A1 MACROLONE COMPOUNDS GLAXO GROUP LIMITED (GB) 2009-03-05 US disclosed
US-20080096829-A1 Macrolone Compounds GLAXO GROUP LIMITED (GB) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062218-A1 MACROLONE COMPOUNDS CYP51A1, MRPL21, MYD88 SIGMAR1 1925/4885P2RY14 2717/4885GSK3B 2763/4885
US-20080096829-A1 Macrolone Compounds MRPL21, MRPS18A, MRPL19 SIGMAR1 601/4885P2RY14 3005/4885GSK3B 3177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.